Publication | Open Access

A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study

MedicineGemcitabine Versus GemcitabineBiliary CancerPharmacologyPhase Ii StudyVangogh StudyPharmacotherapyCancer TreatmentOncologyRadiation Oncology